
            <html>
            <head>
                <title>ADM2 RAMP3 - PMID Details</title>
                <style>
                    .tab { display: flex; }
                    .tab button { margin-right: 5px; padding: 10px; cursor: pointer; }
                    .tabcontent { display: none; padding: 10px; border: 1px solid #ccc; }
                    .tabcontent.active { display: block; }
                </style>
                <script>
                    function openTab(evt, tabId) {
                        // Hide all tabcontents
                        let tabContents = document.getElementsByClassName("tabcontent");
                        for (let i = 0; i < tabContents.length; i++) {
                            tabContents[i].style.display = "none";
                        }
                        // Deactivate all tablinks
                        let tabLinks = document.getElementsByClassName("tablinks");
                        for (let i = 0; i < tabLinks.length; i++) {
                            tabLinks[i].classList.remove("active");
                        }
                        // Show the current tab
                        document.getElementById(tabId).style.display = "block";
                        evt.currentTarget.classList.add("active");
                    }
                </script>
            </head>
            <body>
                <h1>PMID Details for ADM2 RAMP3</h1>
                <div class="tab">
                    <button class="tablinks active" onclick="openTab(event, 'tab30139742')">30139742</button>
                </div>
                
                <div id="tab30139742" class="tabcontent active">
                    <h2>Structure-function analyses reveal a triple Î²-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.</h2>
                    <p>The cardioprotective vasodilator peptide adrenomedullin 2/intermedin (AM2/IMD) and the related adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) signal through three heterodimeric receptors comprising the calcitonin receptor-like class B G protein-coupled receptor (CLR) and a variable receptor activity-modifying protein (RAMP1, -2, or -3) that determines ligand selectivity. The CGRP receptor (RAMP1:CLR) favors CGRP binding, whereas the AM</p>
                </div>
                
            </body>
            </html>
            